The Synthos Flagship
A real-money model portfolio, tracked live against the S&P 500 from its inception on July 4, 2026. No paper trading. No curve-fitted backtest. My own money, public positions, and one honest line on a chart that goes up or down for everyone to see.
This is the proving ground for everything Synthos does. If the research adds an edge, it should show up here — net of the market, in public, over time. If it doesn't, you'll see that too.
The pledge
Most research services sell you a beautiful backtest — a portfolio reverse-engineered to look brilliant in hindsight, then quietly never updated. We're doing the opposite:
- Real money. I'm funding the Flagship personally. Skin in the game — I lose when you would have lost.
- Forward-tracked. The clock starts July 4, 2026. Every data point after that is live, not reconstructed.
- Public positions. The holdings, the weights, and the running return versus the S&P are all on the table.
- No cherry-picking. We will not swap in winners after the fact or restate the start date. The line is the line.
What we are not doing — full disclosure
Honesty cuts both ways, so here's the unflattering part. If you took today's twelve holdings and pretended you'd held them, equal-weight, since January 1, 2026, the basket would have lagged the S&P this year — roughly +1.6% versus +8.6%, about seven points behind.
We're telling you that on purpose. A flattering backtest is the easiest thing in the world to manufacture, and the fact that ours isn't flattering is the point: we're not building a marketing artifact, we're starting a real, forward track record. The only performance number that will ever count here is the one that accrues after July 4 — live.
How it's built
Equal-weight, buy-and-hold, diversified across three sleeves — a balanced expression of the research rather than a concentrated bet:
| Sleeve | Holdings | The idea |
|---|---|---|
| Quality compounders | LLY · AMGN · ISRG | Proven businesses in the diseases of aging — durable revenue, real moats |
| AI exponentials & software | NVDA · META · ORCL · NOW · QCOM | Where genuine AI adoption is compounding, not just narrated |
| Cheap-for-growth | VLO · OXY · FANG · NEM | Screen leaders: positive forward growth at a discount the market is ignoring |
Twelve names, weighted equally, rebalanced rarely. The construction is deliberately simple so the research — not leverage, not trading, not survivorship — is what's being measured.
Track it live
From July 4, 2026, this page carries the running Synthos Flagship line against the S&P 500, updated regularly. Watch it climb, watch it stumble — either way, in public.
Live tracking begins July 4, 2026 — 4 days from today. The chart and the running return appear here the moment the real-money clock starts.
Disclaimer. The Synthos Flagship is a model portfolio published for educational and informational purposes only. It is not investment advice, a recommendation, or a solicitation to buy or sell any security, and it is not personalized to your situation. The author holds, or intends to hold, positions in the securities listed. Past and hypothetical performance does not predict future results. Markets carry risk of loss; do your own due diligence and consult a licensed professional.